Aldeyra Therapeutics IncNASDAQ:ALDX
- LAST PRICE4.1900
- TODAY'S CHANGE (%)0.9300 (28.5276%)
- Bid / Lots4.1000/ 8
- Ask / Lots4.2000/ 10
- Open / Previous Close3.6500 / 3.2600
- Day Range
- 52 Week Range
- Volume4,759,059
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ALDX |
|---|---|---|
| 09:32 ET | 87634 | 3.56 |
| 09:34 ET | 75190 | 3.32 |
| 09:36 ET | 26186 | 3.41 |
| 09:38 ET | 30620 | 3.57 |
| 09:39 ET | 7062 | 3.54 |
| 09:41 ET | 14972 | 3.5399 |
| 09:43 ET | 8849 | 3.57 |
| 09:45 ET | 4339 | 3.5945 |
| 09:48 ET | 8238 | 3.5897 |
| 09:50 ET | 5228 | 3.45 |
| 09:52 ET | 3576 | 3.52 |
| 09:54 ET | 13870 | 3.57 |
| 09:56 ET | 28803 | 3.6299 |
| 09:57 ET | 5206 | 3.6 |
| 09:59 ET | 19371 | 3.545 |
| 10:01 ET | 8859 | 3.52 |
| 10:03 ET | 4038 | 3.5 |
| 10:06 ET | 8521 | 3.47 |
| 10:08 ET | 2458 | 3.4991 |
| 10:10 ET | 520 | 3.48 |
| 10:12 ET | 429 | 3.4991 |
| 10:14 ET | 853 | 3.4911 |
| 10:15 ET | 9129 | 3.51 |
| 10:17 ET | 38771 | 3.58 |
| 10:19 ET | 5222 | 3.605 |
| 10:21 ET | 34231 | 3.725 |
| 10:24 ET | 60375 | 3.71 |
| 10:26 ET | 39603 | 3.735 |
| 10:28 ET | 39737 | 3.81 |
| 10:30 ET | 21041 | 3.7841 |
| 10:32 ET | 8020 | 3.78 |
| 10:33 ET | 5585 | 3.8001 |
| 10:35 ET | 44488 | 3.9 |
| 10:37 ET | 28115 | 3.8599 |
| 10:39 ET | 24548 | 3.78 |
| 10:42 ET | 7303 | 3.8015 |
| 10:44 ET | 18679 | 3.7101 |
| 10:46 ET | 13570 | 3.7363 |
| 10:48 ET | 24295 | 3.76 |
| 10:50 ET | 323 | 3.7401 |
| 10:51 ET | 100 | 3.74 |
| 10:53 ET | 800 | 3.77 |
| 10:55 ET | 486 | 3.764 |
| 10:57 ET | 6507 | 3.7724 |
| 11:00 ET | 3160 | 3.82 |
| 11:02 ET | 7686 | 3.82 |
| 11:04 ET | 12148 | 3.82 |
| 11:06 ET | 3440 | 3.83 |
| 11:08 ET | 5036 | 3.845 |
| 11:09 ET | 2650 | 3.85 |
| 11:11 ET | 2231 | 3.86 |
| 11:13 ET | 4528 | 3.85 |
| 11:15 ET | 37295 | 3.89 |
| 11:18 ET | 2700 | 3.85 |
| 11:20 ET | 632 | 3.87 |
| 11:22 ET | 1400 | 3.87 |
| 11:24 ET | 1823 | 3.8686 |
| 11:26 ET | 2430 | 3.88 |
| 11:27 ET | 8947 | 3.89 |
| 11:29 ET | 11296 | 3.94 |
| 11:31 ET | 6960 | 3.9115 |
| 11:33 ET | 6100 | 3.95 |
| 11:36 ET | 906 | 3.93 |
| 11:38 ET | 1950 | 3.95 |
| 11:40 ET | 7442 | 3.9799 |
| 11:42 ET | 32386 | 4.03 |
| 11:44 ET | 15404 | 4.02 |
| 11:45 ET | 6835 | 4.003 |
| 11:47 ET | 9123 | 4.02 |
| 11:49 ET | 17926 | 4.05 |
| 11:51 ET | 7110 | 4.05 |
| 11:54 ET | 5567 | 4.08 |
| 11:56 ET | 13101 | 4.1606 |
| 11:58 ET | 32217 | 4.095 |
| 12:00 ET | 5189 | 4.12 |
| 12:02 ET | 3779 | 4.0947 |
| 12:03 ET | 1400 | 4.11 |
| 12:05 ET | 2606 | 4.1 |
| 12:07 ET | 1596 | 4.09 |
| 12:09 ET | 2636 | 4.1462 |
| 12:12 ET | 4075 | 4.145 |
| 12:14 ET | 6790 | 4.14 |
| 12:16 ET | 2100 | 4.13 |
| 12:18 ET | 6050 | 4.145 |
| 12:20 ET | 11952 | 4.17 |
| 12:21 ET | 9103 | 4.1996 |
| 12:23 ET | 6984 | 4.1994 |
| 12:25 ET | 27755 | 4.2752 |
| 12:27 ET | 86600 | 4.3153 |
| 12:30 ET | 36784 | 4.42 |
| 12:32 ET | 11764 | 4.4 |
| 12:34 ET | 4476 | 4.425 |
| 12:36 ET | 15996 | 4.374 |
| 12:38 ET | 24159 | 4.49 |
| 12:39 ET | 59461 | 4.4807 |
| 12:41 ET | 49397 | 4.51 |
| 12:43 ET | 206709 | 4.77 |
| 12:45 ET | 185215 | 4.75 |
| 12:48 ET | 211952 | 4.5 |
| 12:50 ET | 265322 | 4.35 |
| 12:52 ET | 133868 | 4.35 |
| 12:54 ET | 103931 | 4.2401 |
| 12:56 ET | 77821 | 4.2108 |
| 12:57 ET | 154197 | 3.975 |
| 12:59 ET | 78524 | 4.08 |
| 01:01 ET | 44819 | 4.17 |
| 01:03 ET | 47835 | 4.12 |
| 01:06 ET | 29362 | 4.08 |
| 01:08 ET | 54773 | 4.157 |
| 01:10 ET | 19547 | 4.22 |
| 01:12 ET | 35907 | 4.1899 |
| 01:14 ET | 6324 | 4.15 |
| 01:15 ET | 16650 | 4.2 |
| 01:17 ET | 3084 | 4.18 |
| 01:19 ET | 8740 | 4.17 |
| 01:21 ET | 2973 | 4.15 |
| 01:24 ET | 17124 | 4.13 |
| 01:26 ET | 6776 | 4.11 |
| 01:28 ET | 31599 | 4.1 |
| 01:30 ET | 60421 | 4.08 |
| 01:32 ET | 34059 | 4.0501 |
| 01:33 ET | 21280 | 4.13 |
| 01:35 ET | 6861 | 4.12 |
| 01:37 ET | 13414 | 4.105 |
| 01:39 ET | 5493 | 4.15 |
| 01:42 ET | 2005 | 4.13 |
| 01:44 ET | 500 | 4.12 |
| 01:46 ET | 6055 | 4.13 |
| 01:48 ET | 3227 | 4.16 |
| 01:50 ET | 4794 | 4.12 |
| 01:51 ET | 5261 | 4.14 |
| 01:53 ET | 13804 | 4.18 |
| 01:55 ET | 12734 | 4.16 |
| 01:57 ET | 13335 | 4.18 |
| 02:00 ET | 1700 | 4.18 |
| 02:02 ET | 11380 | 4.2078 |
| 02:04 ET | 5425 | 4.15 |
| 02:06 ET | 4042 | 4.165 |
| 02:08 ET | 1503 | 4.15 |
| 02:09 ET | 3242 | 4.1301 |
| 02:11 ET | 25586 | 4.13 |
| 02:13 ET | 16086 | 4.15 |
| 02:15 ET | 2050 | 4.1215 |
| 02:18 ET | 8425 | 4.1394 |
| 02:20 ET | 7897 | 4.17 |
| 02:22 ET | 14742 | 4.15 |
| 02:24 ET | 19961 | 4.21 |
| 02:26 ET | 13849 | 4.23 |
| 02:27 ET | 1678 | 4.23 |
| 02:29 ET | 17880 | 4.21 |
| 02:31 ET | 8700 | 4.2199 |
| 02:33 ET | 25328 | 4.18 |
| 02:36 ET | 1300 | 4.18 |
| 02:38 ET | 925 | 4.185 |
| 02:40 ET | 7438 | 4.2178 |
| 02:42 ET | 2703 | 4.2 |
| 02:44 ET | 9675 | 4.19 |
| 02:45 ET | 2250 | 4.1905 |
| 02:47 ET | 50513 | 4.3299 |
| 02:49 ET | 27955 | 4.291 |
| 02:51 ET | 15784 | 4.2799 |
| 02:54 ET | 6639 | 4.27 |
| 02:56 ET | 15925 | 4.245 |
| 02:58 ET | 6656 | 4.2581 |
| 03:00 ET | 990 | 4.25 |
| 03:02 ET | 3464 | 4.25 |
| 03:03 ET | 1958 | 4.26 |
| 03:05 ET | 4063 | 4.31 |
| 03:07 ET | 18491 | 4.3483 |
| 03:09 ET | 1575 | 4.34 |
| 03:12 ET | 8250 | 4.3948 |
| 03:14 ET | 35138 | 4.28 |
| 03:16 ET | 11168 | 4.2913 |
| 03:18 ET | 26777 | 4.24 |
| 03:20 ET | 2598 | 4.22 |
| 03:21 ET | 12067 | 4.22 |
| 03:23 ET | 3052 | 4.23 |
| 03:25 ET | 17338 | 4.18 |
| 03:27 ET | 8016 | 4.17 |
| 03:30 ET | 27355 | 4.14 |
| 03:32 ET | 2394 | 4.1599 |
| 03:34 ET | 6522 | 4.143 |
| 03:36 ET | 9879 | 4.16 |
| 03:38 ET | 3079 | 4.18 |
| 03:39 ET | 18654 | 4.18 |
| 03:41 ET | 5687 | 4.17 |
| 03:43 ET | 8721 | 4.2 |
| 03:45 ET | 6602 | 4.21 |
| 03:48 ET | 5337 | 4.21 |
| 03:50 ET | 10513 | 4.215 |
| 03:52 ET | 5925 | 4.2 |
| 03:54 ET | 118764 | 4.07 |
| 03:56 ET | 32717 | 4.12 |
| 03:57 ET | 19028 | 4.12 |
| 03:59 ET | 60464 | 4.19 |
Today
DJ Aldeyra Therapeutics Shares Rise 9.2% on Trial Outcome for Dry Eye Disease Treatment, from 14 hours ago by Dow Jones
14 hours ago by Dow JonesAldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Clinical Trial of Reproxalap, from 15 hours ago by Dow Jones
15 hours ago by Dow Jones
Yesterday
Aug 2, 2024
DJ Aldeyra Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co., from 8:25AM ET on Friday Aug 02, 2024 by Dow Jones
8:25AM ET on Friday Aug 02, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Aldeyra Therapeutics Inc | 193.7M | -6.6x | --- |
XBiotech Inc | 188.2M | -6.5x | --- |
Trevi Therapeutics Inc | 182.4M | -8.3x | --- |
Pyxis Oncology Inc | 184.3M | -2.5x | --- |
Rezolute Inc | 218.9M | -3.7x | --- |
ESSA Pharma Inc | 201.9M | -7.6x | --- |
Company Information
Aldeyra Therapeutics, Inc. is a biotechnology company, which is engaged in discovering therapies designed to treat immune-mediated diseases. The Company's product candidates include reactive aldehyde species (RASP) modulators ADX-629, ADX-246, ADX-248, and chemically related molecules for the treatment of systemic and retinal immune-mediated diseases. Its pre-commercial product candidates are reproxalap, a RASP modulator for the potential treatment of dry eye disease and allergic conjunctivitis, and ADX-2191, a novel formulation of intravitreal methotrexate for the treatment of proliferative vitreoretinopathy and retinitis pigmentosa. Its ADX-629, is an orally administered RASP modulator in clinical development for atopic dermatitis, idiopathic nephrotic syndrome, moderate alcohol-associated hepatitis, chronic cough, and Sjogren-Larsson Syndrome. Its preclinical RASP platform includes ADX-246 and ADX-248 in development for metabolic, retinal diseases and systemic inflammatory diseases.
Contact Information
- Headquarters
- 131 HARTWELL AVENUE, SUITE 320LEXINGTON, MA, United States 02421
- Phone
- 781-761-4904
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Richard Douglas
- President, Chief Executive Officer, Director
- Todd Brady
- Senior Vice President - Finance, Interim Chief Financial Officer
- Bruce Greenberg
- Chief Development Officer
- Stephen Machatha
- Independent Director
- Ben Bronstein
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $193.7M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 59.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.46 |
EPS | $-0.64 |
Book Value | $2.02 |
P/E Ratio | -6.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
